Document Detail


Safety and efficiency of chronic ACE inhibition in symptomatic heart failure patients with a systemic right ventricle.
MedLine Citation:
PMID:  20843567     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: ACE inhibition is an established treatment regimen in patients with congestive heart failure due to left ventricular dysfunction which improves morbidity and mortality. However, little is known about the beneficial effects of ACE inhibition in adult patients after Mustard procedure for transposition of the great arteries with heart failure symptoms. Therefore, we investigated the effects of ACE inhibition in these patients on heart failure symptoms, echocardiographic diameters, NT-proBNP and exercise capacity.
METHODS: In 14 patients (age 25.2±3.5years), after Mustard procedure for transposition of the great arteries (age at operation 1.1±1.3years) with heart failure NYHA II (New York Heart Association class), an ACE inhibition was initiated. At baseline and 13.3±4.0months after treatment with enalapril (10mg twice a day), echocardiography, exercise test and NT-proBNP measurements were performed and compared to an age- and sex-matched control group.
RESULTS: Maximum oxygen uptake and echocardiographic parameters did not change significantly in both groups. However, NT-proBNP showed a significant decrease in the treatment group (242±105 vs. 151±93ng/l, p=0.004), while in the control group a significant increase (120±89 vs. 173±149ng/l, p<0.05) was observed. Furthermore, ACE inhibitor treatment did not result in a deterioration of heart failure symptoms or renal function.
CONCLUSIONS: Thus, ACE inhibitor treatment of heart failure symptoms in patients with a systemic right ventricle is safe and reduces NT-proBNP levels significantly as a marker for ventricular overload. Nevertheless, larger scale trials are warranted to show effects on morbidity and mortality in this highly selected patient group.
Authors:
Oktay Tutarel; Gerd Peter Meyer; Harald Bertram; Armin Wessel; Bernhard Schieffer; Mechthild Westhoff-Bleck
Related Documents :
9872607 - Parenteral inotropic support for advanced congestive heart failure.
25460847 - Assessment of coronary hemodynamics and vascular function.
22158707 - Thymosin beta 4 is dispensable for murine cardiac development and function.
7907307 - Adaptive changes of the vascular system in heart failure. potential role of impaired en...
17095707 - Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem ce...
19631177 - Biomarkers of myocyte injury in heart failure.
Publication Detail:
Type:  Journal Article     Date:  2010-09-16
Journal Detail:
Title:  International journal of cardiology     Volume:  154     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  14-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Statins moderate coronary stenoses but not coronary calcification: Results from meta-analyses.
Next Document:  Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoin...